Discover the complete record of transactions filed by Young Rodney KB, 首席财务官. Insider active across 1 company, notably RAPT Therapeutics, Inc.. Cumulatively, 1 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €50k. Activity tracked since 10 May 2022. The latest transaction was filed on 10 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Rodney KB Young is the Chief Financial Officer of RAPT Therapeutics, Inc. He is responsible for the company's financial management, including financial planning, risk management, and performance analysis. His financial expertise is essential to support the strategic objectives of RAPT Therapeutics, Inc.